A new treatment is available for more than three million fibromyalgia sufferers in the United States and millions more worldwide. Frequency specific microcurrent (FSM) treatment, initially developed by Dr. Carolyn McMakin in 1995 to treat muscle pain in the head, neck and face, is currently being used by more than 700 qualified practitioners in the U.S. to relieve the suffering of chronic pain sufferers.
Microcurrent treatment was first used in the 1980s in Europe to treat injured sports athletes. Recently approved by the Food and Drug Administration and reviewed in medical journals, FSM therapy works by applying electrical stimulation to patient’s muscles via electronic equipment.
The technique uses microcurrent, which is the same kind of current you own body produces on its own within each cell. During an FSM treatment protocol, specific frequencies are programmed in sequence to communicate with the cells so the cells can produce ATP (cellular energy) and thus begin to heal once again. The frequencies used are based on specific tissue targets and various desired physiologic functions. Because microcurrent is a very small amount of current, a millionth of an ampere, much less than traditional electric stimulation, patients are unable perceive or feel the current.
A doctor administers the treatment using specialized gloves that can detect electron frequencies in a patient’s body. It is called "frequency specific" because a doctor, using the gloves, locates abnormal frequencies in the muscular tissue and utilizes a micro-current to neutralize them. FSM has undergone clinical testing and has been proven to be a safe and non-invasive therapy for fibromyalgia, asthma, lupus, irritable bowel syndrome, Crohn’s disease, endometriosis, shingles, herpes, and sports injuries.
FSM has been shown to help improve circulation, increase energy, repair damaged tissue and detoxify the body. While some patients have reported immediate total recovery a few hours after their first session, others have needed extended therapy (more than one session) to completely eliminate their pain. In a fibromyalgia study of 160 people conducted from 1999 to 2003, patients said their pain reduced from a high pain point of 7.3 to a low pain point of 1.3 after their first treatment.
Microcurrent treatment was first used in the 1980s in Europe to treat injured sports athletes. Recently approved by the Food and Drug Administration and reviewed in medical journals, FSM therapy works by applying electrical stimulation to patient’s muscles via electronic equipment.
The technique uses microcurrent, which is the same kind of current you own body produces on its own within each cell. During an FSM treatment protocol, specific frequencies are programmed in sequence to communicate with the cells so the cells can produce ATP (cellular energy) and thus begin to heal once again. The frequencies used are based on specific tissue targets and various desired physiologic functions. Because microcurrent is a very small amount of current, a millionth of an ampere, much less than traditional electric stimulation, patients are unable perceive or feel the current.
A doctor administers the treatment using specialized gloves that can detect electron frequencies in a patient’s body. It is called "frequency specific" because a doctor, using the gloves, locates abnormal frequencies in the muscular tissue and utilizes a micro-current to neutralize them. FSM has undergone clinical testing and has been proven to be a safe and non-invasive therapy for fibromyalgia, asthma, lupus, irritable bowel syndrome, Crohn’s disease, endometriosis, shingles, herpes, and sports injuries.
FSM has been shown to help improve circulation, increase energy, repair damaged tissue and detoxify the body. While some patients have reported immediate total recovery a few hours after their first session, others have needed extended therapy (more than one session) to completely eliminate their pain. In a fibromyalgia study of 160 people conducted from 1999 to 2003, patients said their pain reduced from a high pain point of 7.3 to a low pain point of 1.3 after their first treatment.
RSS Feed
